A detailed history of Mainstay Capital Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Mainstay Capital Management LLC holds 2,522 shares of NVO stock, worth $220,347. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,522
Previous 2,522 -0.0%
Holding current value
$220,347
Previous $359,000 16.43%
% of portfolio
0.05%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$122.71 - $146.91 $1,595 - $1,909
13 Added 0.52%
2,522 $359,000
Q1 2024

Apr 30, 2024

BUY
$102.11 - $135.92 $5,003 - $6,660
49 Added 1.99%
2,509 $322,000
Q4 2023

Jan 25, 2024

BUY
$87.78 - $105.45 $215,938 - $259,407
2,460 New
2,460 $254,000
Q2 2023

Jul 25, 2023

BUY
$155.98 - $172.65 $208,233 - $230,487
1,335 New
1,335 $216,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mainstay Capital Management LLC Portfolio

Follow Mainstay Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mainstay Capital Management LLC , based on Form 13F filings with the SEC.

News

Stay updated on Mainstay Capital Management LLC with notifications on news.